Journal
LEUKEMIA & LYMPHOMA
Volume 49, Issue 3, Pages 398-409Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428190701851364
Keywords
lymphoma and Hodgkin disease; clinical results; chemotherapeutic approaches
Categories
Ask authors/readers for more resources
Mantle cell lymphoma (MCL) is an aggressive lymphoma requiring intensive chemotherapy +/- autologous stem cell transplantation (SCT) to achieve optimal rates of progression-free survival. Here we review the treatment options for patients with newly-diagnosed or relapsed MCL and discuss recent advances in management, including the role of autologous and allogeneic SCT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
